Area of research
Geriatrics and Gerontology · Family Practice
Research interest
Research interests include Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance, Economic and Financial Impacts of Cancer, and Safe Handling of Antineoplastic Drugs.
Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review
Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
Clinical and economic impact of medication reconciliation in cancer patients: a systematic review
Human‐simulation‐based learning to prevent medication error: A systematic review
No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients
Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
EPICC study: evaluation of pharmaceutical intervention in cancer care
Hypersensitivity to oxaliplatin: clinical features and risk factors
Predictors of prescription errors involving anticancer chemotherapy agents